![]() |
市場調査レポート
商品コード
1625425
胃腸製品市場、規模、シェア、動向、産業分析レポート:デバイス別、疾患別、エンドユーザー別、地域別 - 市場予測、2025年~2034年Gastrointestinal Products Market Size, Share, Trends, Industry Analysis Report: By Devices, Disease, End User, and Region - Market Forecast, 2025-2034 |
||||||
カスタマイズ可能
|
胃腸製品市場、規模、シェア、動向、産業分析レポート:デバイス別、疾患別、エンドユーザー別、地域別 - 市場予測、2025年~2034年 |
出版日: 2024年12月01日
発行: Polaris Market Research
ページ情報: 英文 128 Pages
納期: 即日から翌営業日
|
Polaris Market Research社の最新調査によると、胃腸製品の市場規模は2034年までに258億5,000万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。
胃食道逆流症(GERD)、炎症性腸疾患(IBD)、過敏性腸症候群(IBS)などの胃腸疾患の有病率の上昇は、胃腸製品市場の成長を牽引する一般的な疾患の一つです。これらの疾患は一般的になっているため、効果的な治療に対する需要が高まっており、製薬会社は製品ラインナップの充実を図っています。さらに、ドラッグ製剤やドラッグデリバリーシステムの革新により、より効果的で患者が使用しやすい治療法が開発され、コンプライアンスが向上しています。消化器系の健康に対する意識の高まりと早期介入の重要性は、この動向をさらに強化し、患者が洞察に導かれた治療選択肢をタイムリーに求めるよう促しています。
遠隔医療プラットフォーム、電子カルテ(EHR)、モバイルヘルスアプリケーションなど、特に遠隔医療やデジタルヘルス技術によるヘルスケアにおける技術統合は、消化器ケアの状況を一変させつつあります。これらの技術革新は、患者の医療サービスへのアクセスを向上させ、遠隔診察や消化器疾患の効果的な管理を可能にします。患者は、医療専門家からタイムリーな診断と継続的なサポートを、直接訪問することなく受けることができるようになり、これは特に遠隔地に住む人々にとって有益です。さらに、モバイルヘルスアプリなどのデジタルツールにより、患者は自分の症状をモニターし、食習慣を追跡し、個別化された治療計画を受け取ることができ、より良い健康アウトカムを促進することができます。したがって、このシフトは患者の利便性を向上させ、胃腸の健康管理への積極的なアプローチを促進し、最終的には満足度とコンプライアンスの向上に寄与しています。
疾患別では、2024年には、胃食道逆流症(GERD)が、その広範な有病率と社会的認知の高まりにより、世界の胃腸製品市場の主要セグメントとして浮上しています。
外来手術センター(ASCs)分野は、外来手術への嗜好の高まりによって、胃腸製品市場で急成長を遂げています。
2024年、北米は胃食道逆流症(GERD)や炎症性腸疾患(IBD)などの消化器疾患の流行が主因で、胃腸製品市場をリードしました。
アジア太平洋地域は、ヘルスケア支出の増加、胃腸の健康に対する意識の高まり、生活習慣に関連した問題に取り組む人口の増加などを背景に、予測期間中に最も急成長すると予測されています。
世界の主な市場参入企業には、Abbott Laboratories; Johnson & Johnson; Pfizer Inc.; Bayer AG; Astellas Pharma Inc.; Takeda Pharmaceutical Company; Novartis International AG; GSK (GlaxoSmithKline); Mylan N.V.; Santen Pharmaceutical Co., Ltd.; Dr. Reddy's Laboratories Ltd.が含まれます。
Table 1 Global Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 2 Global Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 3 Global Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 4 North America: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 5 North America: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 6 North America: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 7 US: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 8 US: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 9 US: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 10 Canada: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 11 Canada: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 12 Canada: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 13 Europe: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 14 Europe: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 15 Europe: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 16 UK: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 17 UK: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 18 UK: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 19 France: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 20 France: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 21 France: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 22 Germany: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 23 Germany: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 24 Germany: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 25 Italy: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 26 Italy: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 27 Italy: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 28 Spain: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 29 Spain: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 30 Spain: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 31 Netherlands: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 32 Netherlands: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 33 Netherlands: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 34 Russia: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 35 Russia: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 36 Russia: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 37 Rest of Europe: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 38 Rest of Europe: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 39 Rest of Europe: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 40 Asia Pacific: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 41 Asia Pacific: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 42 Asia Pacific: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 43 China: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 44 China: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 45 China: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 46 India: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 47 India: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 48 India: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 49 Malaysia: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 50 Malaysia: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 51 Malaysia: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 52 Japan: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 53 Japan: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 54 Japan: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 55 Indonesia: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 56 Indonesia: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 57 Indonesia: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 58 South Korea: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 59 South Korea: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 60 South Korea: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 61 Australia: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 62 Australia: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 63 Australia: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 64 Rest of Asia Pacific: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 65 Rest of Asia Pacific: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 66 Rest of Asia Pacific: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 67 Middle East & Africa: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 68 Middle East & Africa: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 69 Middle East & Africa: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 70 Saudi Arabia: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 71 Saudi Arabia: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 72 Saudi Arabia: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 73 UAE: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 74 UAE: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 75 UAE: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 76 Israel: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 77 Israel: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 78 Israel: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 79 South Africa: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 80 South Africa: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 81 South Africa: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 82 Rest of Middle East & Africa: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 83 Rest of Middle East & Africa: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 84 Rest of Middle East & Africa: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 85 Latin America: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 86 Latin America: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 87 Latin America: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 88 Mexico: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 89 Mexico: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 90 Mexico: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 91 Brazil: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 92 Brazil: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 93 Brazil: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 94 Argentina: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 95 Argentina: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 96 Argentina: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 97 Rest of Latin America: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 98 Rest of Latin America: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 99 Rest of Latin America: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
List of Figures:
Figure 1. Global Gastrointestinal Products Market, 2020-2034(USD Billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Price
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Devices
Figure 7. Global Gastrointestinal Products Market, by Devices, 2023 & 2032 (USD Billion)
Figure 8. Market by Disease
Figure 9. Global Gastrointestinal Products Market, by Disease, 2023 & 2032 (USD Billion)
Figure 10. Market by End User
Figure 11. Global Gastrointestinal Products Market, by End User, 2023 & 2032 (USD Billion)
The gastrointestinal products market size is expected to reach USD 25.85 billion by 2034, according to a new study by Polaris Market Research. The report "Gastrointestinal Products Market Size, Share, Trends, Industry Analysis Report: By Devices, Disease, End User (Hospitals, Ambulatory Centers and Independent Diagnostic Centers, Clinics, Other End Users), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa); Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The rising prevalence of gastrointestinal disorders, such as gastroesophageal reflux disease (GERD), inflammatory bowel disease (IBD), and irritable bowel syndrome (IBS), are among the prevailing diseases driving the gastrointestinal products market growth. Since these conditions have become more common, there is a greater demand for effective treatments, prompting pharmaceutical companies to enhance their product offerings. Additionally, innovations in drug formulations and delivery systems have led to the development of therapies that are more effective and easier for patients to use, thereby improving compliance. This growing awareness of digestive health and the importance of early intervention further reinforces this trend, encouraging patients to seek timely treatment options led to insights.
Technological integration in healthcare, such as telemedicine platforms, electronic health records (EHRs), and mobile health applications, particularly through telemedicine and digital health technologies, is transforming the landscape of gastrointestinal care. These innovations enhance patient access to medical services, enabling remote consultations and effective management of gastrointestinal disorders. Patients are now able to receive timely diagnoses and ongoing support from healthcare professionals without the need for in-person visits, which is especially beneficial for those living in remote areas. Additionally, digital tools such as mobile health apps allow patients to monitor their symptoms, track dietary habits, and receive personalized treatment plans, promoting better health outcomes. Therefore, this shift has improved patient convenience, promoting a proactive approach to gastrointestinal health management and ultimately contributing to increased satisfaction and compliance.
In terms of disease, in 2024, gastroesophageal reflux disease (GERD) has emerged as the leading segment in the global gastrointestinal products market due to its widespread prevalence and growing public awareness.
The ambulatory surgical centers (ASCs) segment is witnessing rapid growth in the gastrointestinal products market, driven by an increasing preference for outpatient procedures.
In 2024, North America led the gastrointestinal products market, largely due to the prevalence of gastrointestinal disorders such as gastroesophageal reflux disease (GERD) and inflammatory bowel disease (IBD).
Asia Pacific is projected to experience the fastest growth during the forecast period, driven by increasing healthcare spending, heightened awareness of gastrointestinal health, and a rising population grappling with lifestyle-related issues.
A few global key market players include Abbott Laboratories; Johnson & Johnson; Pfizer Inc.; Bayer AG; Astellas Pharma Inc.; Takeda Pharmaceutical Company; Novartis International AG; GSK (GlaxoSmithKline); Mylan N.V.; Santen Pharmaceutical Co., Ltd.; Dr. Reddy's Laboratories Ltd.
Polaris Market Research has segmented the gastrointestinal products market report on the basis of devices, disease, end user, and region: